Combined Impact of Triglyceride–Glucose Index and Alanine Aminotransferase on Steatotic Liver Disease and Subtypes

Key Points

• Increased baseline triglyceride-glucose index and alanine aminotransferase levels correlate with higher steatotic liver disease risk.
• Individuals with elevated combined TyG index and ALT have a significant link to SLD subtypes, indicating predictive markers.
• Analysis using combined biomarkers helps in early identification of people at risk for liver diseases.
• Findings underline the importance of triglyceride and liver enzyme monitoring for better health outcomes.

Abstract